Author | Yousef N. Zakharia, MD

Articles

Adding Indoximod to Pembrolizumab Improved Response Rate in Advanced Melanoma

April 05, 2017

This video examines phase II results of a single-arm trial that tested checkpoint inhibition plus the IDO–pathway inhibitor indoximod in patients with melanoma.